What makes an mRNA vaccine so effective against severe COVID-19?
A new study by researchers at Washington University School of Medicine and St. Jude Children’s Research Hospital helps explain why mRNA vaccines have been so successful at preventing severe disease.
Grants fund drug development for devastating tropical diseases
Researchers at Washington University School of Medicine are working to develop new treatments for two types of devastating parasitic infections common in sub-Saharan Africa and Central and South America: river blindness and intestinal worm infections.
$11.5 million commitment supports new Alzheimer’s prevention clinical trial
Longtime St. Louis benefactor Joanne Knight has committed up to $11.5 million to Washington University School of Medicine in St. Louis to support an innovative clinical trial aimed at preventing Alzheimer’s disease by treating people before the first signs of the illness appear in the brain.
New Alzheimer’s prevention trial in young people
Researchers at Washington University School of Medicine are conducting an Alzheimer’s prevention trial with young adults from high-risk families to evaluate whether an investigational drug can clear a key Alzheimer’s protein, amyloid beta, and slow or stop the disease.
De Fer named director of Division of General Medicine
Thomas M. De Fer, MD, a nationally recognized leader in medical education, has been named director of the Division of General Medicine within the Department of Medicine at Washington University School of Medicine.
Galletto to study DNA helicases
Roberto Galletto at the School of Medicine received a five-year $2.1 million MIRA grant from the National Institutes of Health (NIH).
Marcus receives NIH grant
Daniel Scott Marcus, professor of radiology at the School of Medicine, received a one-year $2 million grant from the National Institutes of Health (NIH).
Griffith wins NSF grant
Daniel Griffith, a predoctoral trainee in biochemistry at the School of Medicine, received a three-year $138,000 Graduate Research Fellowship award from the National Science Foundation.
Kerschensteiner to research visual pathways
Daniel Kerschensteiner, MD, professor of ophthalmology and visual sciences at the School of Medicine, received a five-year $2 million grant from the National Eye Institute of the National Institutes of Health (NIH) to study visual pathways.
NIH research funding to School of Medicine continues explosive expansion in 2021
Researchers at the School of Medicine were awarded $575.8 million in funding from the National Institutes of Health (NIH) in federal fiscal year 2021, according to the School of Medicine’s 2021 State of the School Report. This is an all-time high for the school.
View More Stories